Search

Damien J Chaussabel

from Wilton, CT
Age ~50
Get Report
Also known as:
Damien L
Related to:
Adrien M Chaussabel, 28Phuong M Nguyen, 49Quyen N Nguyen, 44Karen M Chaussabel, 53Anh N Steimel, 44Dungkim Nguyen Vu, 84Kinh P NguyenHugh Nguyen, 50Phuoc Q Nguyen, 51Ngan Nguyen, 44Dangkhoa V Nguyen, 56Thi Q Nguyen, 58Celia Chaussabel, 28Quynh Anh Nguyen, 53Trung P Nguyen, 55
Connected to:
Cari S Chauss, 65Garrett Chaussard, 41Amberlee E Chaussee, 51Catherine C Chausse, 74Mary T Chausse, 56Michael D Chaussee, 72Nathan D Chausse, 30Stephen A Chausse, 42Ann Chauvet, 57Berenice D Chauvet, 60

Damien Chaussabel Phones & Addresses

  • Wilton, CT
  • New York, NY
  • Bainbridge Island, WA
  • 3500 Northstar Rd, Richardson, TX 75082 (972) 231-9492
  • 4532 Southpointe Dr, Richardson, TX 75082
  • 115 Lamont Ln, Gaithersburg, MD 20878 (240) 631-2176
  • Colton, TX
  • Dallas, TX
  • Bainbridge Is, WA
  • 115 Lamont Ln, Gaithersburg, MD 20878 (301) 631-2176

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Bachelor's degree or higher

Public records

Vehicle Records

Damien Chaussabel

View page
Address:
4532 Southpointe Dr, Richardson, TX 75082
VIN:
JHLRE38777C041832
Make:
HONDA
Model:
CR-V
Year:
2007

Publications

Us Patents

Module-Level Analysis Of Peripheral Blood Leukocyte Transcriptional Profiles

View page
US Patent:
20070231816, Oct 4, 2007
Filed:
Dec 9, 2006
Appl. No.:
11/608815
Inventors:
Damien Chaussabel - Richardson TX, US
Jacques Banchereau - Dallas TX, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
International Classification:
C12Q 1/68
C07H 21/02
C07H 21/04
US Classification:
435006000, 536024310
Abstract:
The present invention includes an apparatus, system and method for the development and use of transcriptional modules by obtaining individual gene expression levels from cells obtained from one or more patients with a disease or condition; recording the expression value for each gene in a table that is divided into clusters; iteratively selecting gene expression values for one or more transcriptional modules by: selecting for the module the genes from each cluster that match in every disease or condition; removing the selected genes from the analysis; and repeating the process of gene expression value selection for genes that cluster in a sub-fraction of the diseases or conditions; and iteratively repeating the generation of modules.

Diagnosis, Prognosis And Monitoring Of Disease Progression Of Systemic Lupus Erythematosus Through Blood Leukocyte Microarray Analysis

View page
US Patent:
20070238094, Oct 11, 2007
Filed:
Jun 5, 2006
Appl. No.:
11/446825
Inventors:
Damien Chaussabel - Richardson TX, US
Maria Pascual - Dallas TX, US
Jacques Banchereau - Dallas TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
C12Q 1/70
C12Q 1/68
C12M 3/00
US Classification:
435005000, 435006000, 435287200
Abstract:
The present invention includes compositions, systems, arrays and methods for the early detection and consistent determination of SLE using modular analysis of gene expression data.

Gene Expression Signatures In Blood Leukocytes Permit Differential Diagnosis Of Acute Infections

View page
US Patent:
20080171323, Jul 17, 2008
Filed:
Aug 10, 2007
Appl. No.:
11/837237
Inventors:
Jacques F. Banchereau - Dallas TX, US
Anna Karolina Palucka - Dallas TX, US
Octavio Ramilo - Dallas TX, US
Damien Chaussabel - Richardson TX, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
C12Q 1/68
C40B 30/04
G01N 33/53
G06G 7/48
US Classification:
435 6, 506 9, 435 792, 703 11
Abstract:
The present invention includes compositions, systems and methods for the early detection and consistent determination of the extent, type and nature of a host immune response and the nature of the infectious disease using gene expression data.

Gene Expression In Peripheral Blood Mononuclear Cells From Children With Diabetes

View page
US Patent:
20080227709, Sep 18, 2008
Filed:
Mar 12, 2008
Appl. No.:
12/046874
Inventors:
Maria Virginia Pascual - Dallas TX, US
Jacques F. Banchereau - Dallas TX, US
Damien J. Chaussabel - Richardson TX, US
Ellen Kaizer - Dallas TX, US
Perrin C. White - Dallas TX, US
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 38/00
A61K 31/70
C12Q 1/68
C12Q 1/02
A61P 3/10
C40B 30/04
G01N 33/53
US Classification:
514 12, 514 44, 435 6, 435 29, 506 9, 435 792, 702 19
Abstract:
The present invention includes composition, methods and systems for detecting, evaluating, diagnosis, tracking and treating Type 1 Diabetes by determining the level of expression of one or more genes listed in Table 1 (e.g., interleukin-1β (IL1B), early growth response gene 3 (EGR3), and prostaglandin-endoperoxide synthase 2 (PTGS2)). The present invention also includes compositions and methods for treating a patient in need thereof with a composition having a therapeutically effective amount of one or more IL-1β antagonists sufficient to spare pancreatic beta cells, including an anti-IL-1β receptor and downstream activators.

Diagnosis Of Metastatic Melanoma And Monitoring Indicators Of Immunosuppression Through Blood Leukocyte Microarray Analysis

View page
US Patent:
20100076691, Mar 25, 2010
Filed:
Nov 3, 2007
Appl. No.:
12/513344
Inventors:
Anna Karolina Palucka - Dallas TX, US
Jacques F. Banchereau - Dallas TX, US
Damien Chaussabel - Richardson TX, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
C12Q 1/68
C40B 30/00
C40B 40/06
G06F 19/00
US Classification:
702 19, 435 6, 506 7, 506 16
Abstract:
The present invention includes compositions, systems and methods for the early detection and consistent determination of metastatic melanoma and/or immunosuppression using microarrays by calculating one or more expression vectors from the expression of one or more genes.

Blood Transcriptional Signature Of Active Versus Latent Mycobacterium Tuberculosis Infection

View page
US Patent:
20110129817, Jun 2, 2011
Filed:
Nov 30, 2009
Appl. No.:
12/628148
Inventors:
Jacques F. Banchereau - Dallas TX, US
Damien Chaussabel - Richardson TX, US
Anne O'Garra - London, GB
Matthew Berry - London, GB
Onn Min Kon - London, GB
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
NATIONAL INSTITUTE FOR MEDICAL RESEARCH - London
IMPERIAL COLLEGE HEALTHCARE NHS TRUST - London
International Classification:
C12Q 1/68
C12M 1/34
US Classification:
435 6, 4352872
Abstract:
The present invention includes methods, systems and kits for distinguishing between active and latent infection in a patient suspected of being infected with , the method including the steps of obtaining a patient gene expression dataset from a patient suspected of being infected with ; sorting the patient gene expression dataset into one or more gene modules associated with infection; and comparing the patient gene expression dataset for each of the one or more gene modules to a gene expression dataset from a non-patient; wherein an increase or decrease in the totality of gene expression in the patient gene expression dataset for the one or more gene modules is indicative of active infection.

Blood Transcriptional Signature Of Mycobacterium Tuberculosis Infection

View page
US Patent:
20110196614, Aug 11, 2011
Filed:
Jun 25, 2009
Appl. No.:
12/602488
Inventors:
Jacques F. Banchereau - Dallas TX, US
Damien Chaussabel - Bainbridge Island WA, US
Anne O'Garra - London, GB
Matthew Berry - London, GB
Onn Min Kon - London, GB
Assignee:
BAYLOR RESEARCH INSTITUTE - Dallas TX
NATIONAL INSTITUTE FOR MEDICAL RESEARCH - London
IMPERIAL COLLEGE HEALTHCARE NHS TRUST - London
International Classification:
G06F 19/00
G01N 33/48
US Classification:
702 19
Abstract:
The present invention includes methods, systems and kits for distinguishing between active and latent infection in a patient suspected of being infected with and distinguishing such patients from uninfected individuals, the method including the steps of obtaining a gene expression dataset from a whole blood obtained sample from the patient and determining the differential expression of one or more transcriptional gene expression modules that distinguish between infected and non-infected patients, wherein the dataset demonstrates an aggregate change in the levels of polynucleotides in the one or more transcriptional gene expression modules as compared to matched non-infected patients, thereby distinguishing between active and latent infection.

Genomic Transcriptional Analysis As A Tool For Identification Of Pathogenic Diseases

View page
US Patent:
20110312521, Dec 22, 2011
Filed:
May 12, 2011
Appl. No.:
13/106108
Inventors:
Damien Chaussabel - Bainbridge Island WA, US
Assignee:
Baylor Research Institute - Dallas TX
International Classification:
C40B 30/04
C40B 40/08
C07H 21/04
US Classification:
506 9, 536 2431, 506 17
Abstract:
The discovery and validation of a candidate biomarker signature for the diagnosis of sepsis, and more particularly septicemic meliodiosis, based on genomic transcriptional profiling using microarrays is described herein. The microarray technology of the instant invention generates genome-wide transcriptional profiles (>48,000 transcripts) from the whole blood of patients with septicemic melioidosis (n=32), patients with sepsis caused by other pathogens (n=31), and uninfected controls (n=29). Unsupervised analyses demonstrated the existence of a whole blood transcriptional signature distinguishing patients with sepsis from control subjects.
Control profile
Damien J Chaussabel from Wilton, CT, age ~50 Get Report